Japanese researchers sought to build upon prior studies demonstrating the feasibility of liver resection in geriatric hepatocellular carcinoma patients, particularly in those undergoing major ...

On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.

[56] At 9 months of follow-up, the sustained objective response (European Association for the Study of the Liver [EASL ... for the management of hepatocellular carcinoma (HCC) without curative ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Hepatocellular cancer, the most common form of primary liver cancer, is the fastest rising cause of cancer-related deaths in the United States. Texas has the highest incidence rates of HCC in the ...

[13] The studies included in our review were identified by searching Medline using the following key words: 'hepatocellular carcinoma' or 'HCC' or 'hepatic tumor' or 'liver tumor' or 'hepatic ...